Phosphorylated Ser187-SNAP25-modulated Hyperfunction of Glutamatergic System in the Vmpfc Mediates Depressive-Like Behaviors in Male Mice.

Xinjuan Wang,Xueyu Hou,Yu Huo,Di Wang,Xiang Fan,Xiaorui Lin,Weidong Yu,Cailian Cui,Jingzhu Guo,Yijing Li
DOI: https://doi.org/10.1016/j.neuropharm.2023.109691
IF: 5.273
2023-01-01
Neuropharmacology
Abstract:Dysfunctional glutamatergic neurotransmission contributes importantly to the pathophysiology of depression. However, the underlying neural mechanisms of glutamatergic dysfunction remain poorly understood. Here, we employed chronic unpredictable mild stress (CUMS) to induce depression-like behavior in male mice and to assess the alterations of glutamatergic system within the ventromedial prefrontal cortex (vmPFC). Male mice subjected to CUMS showed an increase in levels of glutamate content, synaptosomal GluN2B-NMDA receptors (GluN2B-NMDARs) and phosphorylated synaptosomal associated protein 25 KD of Ser187 (pSer187-SNAP25), which is involved in synaptic vesicular fusion processes in the vmPFC. Downregulation of pSer187-SNAP25 via the TAT-S187 fusion peptide efficiently alleviated CUMS-induced depressive-like behaviors in male mice by reversing the increase of glutamate content and synaptosomal GluN2B-NMDARs. These findings demonstrated a critical role for pSer187-SNAP25-mediated glutamatergic dysfunction in CUMS-induced depressive-like behaviors, suggesting the potential of pS187-SNAP25 inhibitors for further investigation on depression management.
What problem does this paper attempt to address?